Search Results - "Assmus, Birgit"

Unacceptably high mortality and readmission rates 5 years after heart failure hospitalization: The need to optimize long‐term heart failure care by addressing diverse healthcare resources.

Authors: Assmus, Birgit Rakisheva, Amina

Source: European Journal of Heart Failure. Mar2025, Vol. 27 Issue 3, p432-434. 3p.

Myeloperoxidase: Reviving an old ally for immunomodulation in heart failure?

Authors: Kuster, Gabriela M. Assmus, Birgit Mahfoud, Felix

Source: European Journal of Heart Failure. Mar2025, Vol. 27 Issue 3, p555-557. 3p.

What we claim to do and what we really do – a discrepancy in heart failure treatment.

Authors: Assmus, Birgit Sossalla, Samuel

Source: European Journal of Heart Failure. Jun2024, Vol. 26 Issue 6, p1419-1422. 4p.

Effects of remote haemodynamic‐guided heart failure management in patients with different subtypes of pulmonary hypertension: insights from the MEMS‐HF study.

Authors: Assmus, Birgit Angermann, Christiane E. Alkhlout, Basil et al.

Source: European Journal of Heart Failure. Dec2022, Vol. 24 Issue 12, p2320-2330. 11p. 5 Charts, 3 Graphs.

Pulmonary artery pressure-guided therapy in ambulatory patients with symptomatic heart failure: the CardioMEMS European Monitoring Study for Heart Failure (MEMS-HF).

Authors: Angermann, Christiane E. Assmus, Birgit Anker, Stefan D. et al.

Source: European Journal of Heart Failure. Oct2020, Vol. 22 Issue 10, p1891-1901. 11p. 2 Diagrams, 2 Charts, 3 Graphs.

Telemonitoring for Chronic Heart Failure: Narrative Review of the 20-Year Journey From Concept to Standard Care in Germany.

Authors: Spethmann, Sebastian Hindricks, Gerhard Koehler, Kerstin et al.

Source: Journal of Medical Internet Research; 2024, Vol. 26, p1-16, 16p

Intracoronary infusion of bone marrow-derived mononuclear cells abrogates adverse left ventricular remodelling post-acute myocardial infarction: insights from the reinfusion of enriched progenitor cells and infarct remodelling in acute myocardial ...

Authors: Schächinger, Volker Assmus, Birgit Erbs, Sandra et al.

Source: European Journal of Heart Failure. Oct2009, Vol. 11 Issue 10, p973-979. 7p. 2 Charts, 2 Graphs.

A novel cardiac extracorporeal shock wave for enhancing the efficacy of cell therapy.

Authors: Khaled, Walaa Assmus, Birgit Lutz, Andreas et al.

Source: AIP Conference Proceedings. Nov2012, Vol. 1503 Issue 1, p46-49. 4p. 1 Chart, 2 Graphs.

Effect of shock wave-facilitated intracoronary cell therapy on LVEF in patients with chronic heart failure: the CELLWAVE randomized clinical trial.

Authors: Assmus, Birgit Walter, Dirk H Seeger, Florian H et al.

Source: JAMA: Journal of the American Medical Association. 4/17/2013, Vol. 309 Issue 15, p1622-1631. 10p.

Red Blood Cell Contamination of the Final Cell Product Impairs the Efficacy of Autologous Bone Marrow Mononuclear Cell Therapy

Authors: Assmus, Birgit Tonn, Torsten Seeger, Florian H. et al.

Source: Journal of the American College of Cardiology (JACC). Mar2010, Vol. 55 Issue 13, p1385-1394. 10p.

Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction: Final one-year results of the TOPCARE-AMI Trial

Authors: Schächinger, Volker Assmus, Birgit Britten, Martina B. et al.

Source: Journal of the American College of Cardiology (JACC). Oct2004, Vol. 44 Issue 8, p1690-1699. 10p.

Impact of SGLT2 Inhibitor Therapy on Patients Undergoing Cardiac Surgery.

Authors: Taghiyev, Zulfugar T. Beier, Lili-Marie Leweling, Carina et al.

Source: Thoracic & Cardiovascular Surgeon. Apr2026, Vol. 74 Issue 3, p220-231. 12p.

Case Series Evaluating the Relationship of SGLT2 Inhibition to Pulmonary Artery Pressure and Non-Invasive Cardiopulmonary Parameters in HFpEF/HFmrEF Patients—A Pilot Study.

Authors: Herrmann, Ester Judith Guckert, Michael Gruen, Dimitri et al.

Source: Sensors (14248220). Feb2025, Vol. 25 Issue 3, p605. 14p.

Changes in Renal Venous Flow and Liberation from Renal Replacement Therapy in Patients with Acute Heart Failure.

Authors: Husain-Syed, Faeq Vaughan, Lisa Bauer, Pascal et al.

Source: CardioRenal Medicine. 2025, Vol. 15 Issue 1, p535-543. 9p.

Hereditary Transthyretin-Related Amyloidosis Ongoing Observational Study: A Baseline Report of the First 3167 Participants.

Authors: Rösner, Sabine Pardo, Luba M. Bertoli-Avella, Aida M. et al.

Source: Journal of Clinical Medicine. Oct2024, Vol. 13 Issue 20, p6197. 15p.

THE ASSOCIATION OF CLONAL HEMATOPOIESIS OF INDETERMINATE POTENTIAL WITH CHRONIC ISCHEMIC HEART FAILURE.

Authors: Dorsheimer, Lena Assmus, Birgit Rasper, Tina et al.

Source: Experimental Hematology. Aug2019 Supplement, Vol. 76, pS64-S65. 2p.

The effect of intracoronary infusion of bone marrow-derived mononuclear cells on all-cause mortality in acute myocardial infarction: rationale and design of the BAMI trial.

Authors: Mathur, Anthony Arnold, Roman Assmus, Birgit et al.

Source: European Journal of Heart Failure. Nov2017, Vol. 19 Issue 11, p1545-1550. 6p.

Comparison of preoperative NT-proBNP and simple cardiac risk scores for predicting postoperative morbidity after non-cardiac surgery with intermediate or high surgical risk.

Authors: Schmidt, Götz Frieling, Nora Schneck, Emmanuel et al.

Source: Perioperative Medicine. 5/17/2024, Vol. 13, p1-12. 12p.

Preoperative routine measurement of NT-proBNP predicts postoperative morbidity after non-cardiac surgery with intermediate or high surgical risk: an observational study.

Authors: Schmidt, Götz Frieling, Nora Schneck, Emmanuel et al.

Source: BMC Anesthesiology. 3/23/2024, Vol. 24 Issue 1, p1-13. 13p.

A Novel Rat Model of Mild Pulmonary Hypertension Associated with Pulmonary Venous Congestion Induced by Left Pulmonary Vein Banding.

Authors: Münks, Jonas Yogeswaran, Athiththan Antoine, Tobiah Kevin et al.

Source: International Journal of Molecular Sciences. Mar2024, Vol. 25 Issue 5, p2827. 16p.